QUOTED. 3 September 2019. Beth McQuiston.
Executive Summary
A landmark study of Abbott's point-of-care blood test for traumatic brain injuries shows the test could identify patients who should undergo magnetic resonance imaging (MR) even after a computed tomography (CT) scan did not show a brain injury. See what Beth McQuiston, medical director for Abbott Diagnostics' division said about it here.
“We've got a blood test for [injuries to] the heart, the liver, and the kidneys; it's about time we had one for the brain. Any technology that is being used or considered should be built on robust proven research and validation, and that’s why a landmark study like this is exciting.” – Beth McQuiston, medical director, Abbott Diagnostics
Click here for a free trial of Medtech Insight